Literature DB >> 11567228

Low-affinity nerve growth factor receptor (p75) in dermatofibrosarcoma protuberans and other nonneural tumors: a study of 1,150 tumors and fetal and adult normal tissues.

J C Fanburg-Smith1, M Miettinen.   

Abstract

Low-affinity nerve growth factor receptor (p75) is a member of the tumor necrosis factor receptor family. It may modulate the binding of nerve growth factor (NGF) to the functional high-affinity receptor tyrosine kinase (trk) A. NGF is thought to be responsible for growth, apoptosis, and function of the nervous system. The presence of this receptor (p75) was determined in a large group of neural and nonneural tumors and fetal and adult tissues. One thousand one hundred fifty tumors were analyzed with monoclonal antibody for p75, along with selected normal fetal and adult tissues. Immunoreactivity for p75 was present in adult pericytes, perivascular fibroblasts, basal cells of several types of epithelia, perineurial cells, and dendritic reticulum cells. Additionally, a wide zone of subepithelial mesenchyme and skeletal muscle were positive in the first-trimester fetus, but were diminished or negative in the adult. Consistently positive nonneural mesenchymal tumors included dermatofibrosarcoma protuberans (DFSP), embryonal and alveolar rhabdomyosarcoma, synovial sarcoma, and spindle cell hemangio(endotheli)oma. Schwann cell tumors, ganglioneuroma, granular cell tumor, and malignant peripheral nerve sheath tumor (MPNST) were also p75 positive. Mesenchymal nonneural tumors that were variably positive (32% to 69%) for p75 included fibrosarcoma variants, solitary fibrous tumor, hemangiopericytoma, spindle cell lipoma, Ewing's sarcoma, mesenchymal chondrosarcoma, and malignant melanoma. Nervous system tumors such as paragangliomas, neuroblastoma, meningioma, and perineurioma and nonneural mesenchymal tumors, including extraskeletal osteosarcoma, benign fibrous histiocytomas, fibromas, alveolar soft part sarcoma, epithelioid sarcoma, smooth muscle and gastrointestinal stromal tumors, and angiosarcomas, were almost always negative for p75. Epithelial tumors that were consistently positive included mixed tumor and adenoid cystic carcinoma, whereas mesothelioma, adenocarcinomas, and most squamous cell carcinomas were negative. p75 is not a specific marker for nerve sheath tumors. It is present in a variety of other mesenchymal tumors including synovial sarcoma and in CD34-positive tumors such as DFSP, spindle cell lipoma, and hemangiopericytoma. The presence of p75 in nonneural tumors such as DFSP and rhabdomyosarcoma mimic its presence in early fetal mesenchyme and skeletal muscle, suggesting oncofetal expression in these tumors. p75 may be useful to distinguish DFSP from benign fibrous histiocytoma.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11567228     DOI: 10.1053/hupa.2001.27602

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  14 in total

1.  A Multikinase and DNA-PK Inhibitor Combination Immunomodulates Melanomas, Suppresses Tumor Progression, and Enhances Immunotherapies.

Authors:  Alexander K Tsai; Asra Y Khan; Christina E Worgo; Lucy L Wang; Yuanyuan Liang; Eduardo Davila
Journal:  Cancer Immunol Res       Date:  2017-08-03       Impact factor: 11.151

2.  Detection of perineural spread: fat suppression versus no fat suppression.

Authors:  Hugh D Curtin
Journal:  AJNR Am J Neuroradiol       Date:  2004-01       Impact factor: 3.825

Review 3.  [Cerebral nerves - perineural tumor spread].

Authors:  S Bisdas; M G Mack
Journal:  Radiologe       Date:  2009-07       Impact factor: 0.635

Review 4.  Cardiovascular actions of neurotrophins.

Authors:  Andrea Caporali; Costanza Emanueli
Journal:  Physiol Rev       Date:  2009-01       Impact factor: 37.312

5.  Comparision of New Diagnostic Tools for Malignant Peripheral Nerve Sheath Tumors.

Authors:  Ayca Ersen; Melike Pekmezci; Andrew L Folpe; Tarik Tihan
Journal:  Pathol Oncol Res       Date:  2016-10-12       Impact factor: 3.201

6.  Morphologic and immunohistochemical features of malignant peripheral nerve sheath tumors and cellular schwannomas.

Authors:  Melike Pekmezci; David E Reuss; Angela C Hirbe; Sonika Dahiya; David H Gutmann; Andreas von Deimling; Andrew E Horvai; Arie Perry
Journal:  Mod Pathol       Date:  2014-09-05       Impact factor: 7.842

7.  Diagnostic value of neurotrophin expression in malignant pleural effusions.

Authors:  Bernard C Duysinx; Astrid Paulus; Vincent Heinen; Delphine Nguyen; Monique Henket; Jean-Louis Corhay; Renaud Louis
Journal:  Exp Ther Med       Date:  2011-06-30       Impact factor: 2.447

Review 8.  Imaging of perineural spread in head and neck tumours.

Authors:  C K Ong; V F-H Chong
Journal:  Cancer Imaging       Date:  2010-10-04       Impact factor: 3.909

9.  Skeletal muscle pericyte subtypes differ in their differentiation potential.

Authors:  Alexander Birbrair; Tan Zhang; Zhong-Min Wang; Maria Laura Messi; Grigori N Enikolopov; Akiva Mintz; Osvaldo Delbono
Journal:  Stem Cell Res       Date:  2012-09-29       Impact factor: 2.020

10.  ProNGF, a cytokine induced after myocardial infarction in humans, targets pericytes to promote microvascular damage and activation.

Authors:  Chia-Jen Siao; Christina U Lorentz; Pouneh Kermani; Tina Marinic; John Carter; Kelly McGrath; Victoria A Padow; Willie Mark; Domenick J Falcone; Leona Cohen-Gould; Diana C Parrish; Beth A Habecker; Anders Nykjaer; Lora H Ellenson; Lino Tessarollo; Barbara L Hempstead
Journal:  J Exp Med       Date:  2012-10-22       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.